EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Bile acids in the treatment of hepatobiliary diseases: rational use of UDCA

Petra Halvová

Česká a slovenská farmacie · 10.06.2026 · 75 (2) · 79-82

DOI: 10.36290/csf.2026.014 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Česká a slovenská farmacie, erschienen am 10.06.2026. Verfasst von Petra Halvová. Hauptthemen laut MEDLINE: Ursodeoxycholic Acid, Cholagogues and Choleretics, Liver Diseases. Die Arbeit nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ursodeoxycholic acid (UDCA) is a hydrophilic, non-toxic bile acid that represents the gold standard in the treatment of various cholestatic and hepatobiliary diseases. Its therapeutic benefit lies in its complex pleiotropic mechanism of action, including cytoprotection of hepatocytes and cholangiocytes, stimulation of hepatobiliary secretion, antiapoptotic effects, and immunomodulatory properties. This article comprehensively summarizes the pharmacological characteristics of UDCA and its rational clinical use in key indications such as primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), dissolution of cholesterol gallstones, reactive gastritis due to duodenogastric reflux, and intrahepatic cholestasis of pregnancy (ICP). Furthermore, it focuses on the safety profile of UDCA, including its excellent tolerability, dose-dependent diarrhea, and confirmed safety for use during pregnancy and lactation, making it a crucial drug in hepatology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ursodeoxycholic AcidCholagogues and CholereticsLiver DiseasesHumansPregnancy ComplicationsPregnancyCholestasis, IntrahepaticFemaleCholangitis, Sclerosing

Stichwörter der Autor:innen

Cholelithiasisduodenogastric refluxintrahepatic cholestasis of pregnancy.primary biliary cholangitisprimary sclerosing cholangitisursodeoxycholic acid

Substanzen

Ursodeoxycholic AcidCholagogues and Choleretics

Zitieren

APA

Halvová, P. (2026). Bile acids in the treatment of hepatobiliary diseases: rational use of UDCA. Česká a slovenská farmacie, 75(2), 79-82. https://doi.org/10.36290/csf.2026.014

Vancouver

Halvová P. Bile acids in the treatment of hepatobiliary diseases: rational use of UDCA. Česká a slovenská farmacie. 2026;75(2):79-82. doi:10.36290/csf.2026.014

BibTeX
@article{Halvov2026,
  author = {Halvová, Petra},
  title = {Bile acids in the treatment of hepatobiliary diseases: rational use of UDCA},
  journal = {Česká a slovenská farmacie},
  year = {2026},
  volume = {75},
  number = {2},
  pages = {79--82},
  doi = {10.36290/csf.2026.014}
}
Kostenlos starten →